DadFinStart your free week
DadFin › Stocks › Financial Services › OBDC

Blue Owl Capital Corporation (OBDC) stock score

Financial Services · Asset Management · United States

$10.11 ▼ -0.59% today

77.7
Dad Score, out of 100
good

Blue Owl Capital Corporation (OBDC) is a Asset Management company in the Financial Services sector, listed in the United States. On DadFin's weekly run it scores 77.7 out of 100 on the Dad Score, a good reading that places the business ahead of 78% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Financial Services it ranks #357 of 1,228. Its strongest axes are valuation, quality and risk; its weakest is growth.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Strong
Quality
Above average
Growth
Below average
Price action
Average
Risk
Above average
Conviction
Average
Liquidity
Strong
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)18.4×
P/E (forward)7.9×
Dividend yield13.60%
Return on capital7.0%
Operating margin74.7%
Revenue growth (YoY)+6.6%
FCF yield38.2%
Net debt / EBITDA3.00×
Piotroski F-Score3 / 9
52-week change-7.1%
Market cap$5.1B
Next earningsNov 4, 2026

What subscribers see on OBDC

Start your free weekSubscriber? Open the full research →

Asset Management peers

StockCompanyDad ScoreBandMarket cap
BLKBlackRock, Inc.78.8good$172.2B
BXBlackstone Inc.62.7middling$133.6B
KKRKKR & Co. Inc.14.3poor$83.4B
BNBrookfield Corporation17.2weak$82.4B
BAMBrookfield Asset Management Ltd.35.6weak$71.6B
APOApollo Global Management, Inc.65.4middling$67.3B
STTState Street Corporation69.6middling$48.3B
AMPAmeriprise Financial, Inc.96.7strong$43.4B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.